Introduction {#sec1}
============

Intramuscular capillary-type hemangioma now called *intramuscular hemangioma* (IMH) has been defined recently and is classified in the category of "provisionally unclassified vascular anomalies," according to the latest revision of the International Society for the Study of Vascular Anomalies classification.[@bib1] Several reported cases of IMH have been misdiagnosed and confused with common intramuscular venous malformations.[@bib2] Here we report the case of a 3-year-old child who had an IMH presenting as a rapidly growing mass.

Case report {#sec2}
===========

A 3-year-old boy was referred for a mass on the right side of his back ([Fig 1](#fig1){ref-type="fig"}). He was born at 38 weeks\' gestation after an uncomplicated pregnancy. The mass was absent at birth and was observed at the age of 1 year. At this age, an ultrasonography performed in another care center showed a well-circumscribed, high-flow vascular lesion within the right *Latissimus dorsi* muscle surrounded by increased fat density. Magnetic resonance imaging at that time identified a well-delineated intramuscular tissue lesion of 33 × 21 × 12 mm with flow void, without phleboliths, sparing the adjacent structures. Signals were isointense on the T1-weighted image and hyperintense on the T2-weighted image with early intense homogeneous contrast enhancement after gadolinium injection. He and his parents then lived abroad for 2 years and no follow-up was carried out.Fig 1Skin-colored mass localized on the right side of the back of a 3-year-old child.

When the child was 3 years old, he returned to France and because of the persistent growth of the lesion, the child was referred to our department. The physical examination found an indurated, skin-colored, nonpulsatile, fixed, nontender tumor measuring 45 mm in diameter with some superficial telangiectasias. The rest of the clinical examination was normal. Ultrasonography examination identified a high-flow vascular lesion of stable echo structure, with a size increase of 30% (41 × 15 × 18 mm) from the previous measurement. Given the uncertainty of the diagnosis, a percutaneous biopsy was performed. The histologic analysis found lobules and sheets of regular, small-diameter capillaries lined with plump endothelial cells lying between skeletal muscle fibers. No intra- or perilesional fat contingent was observed ([Fig 2](#fig2){ref-type="fig"}, *A*). Immunohistochemical staining was negative for GLUT-1 (glucose transporter 1) ([Fig 2](#fig2){ref-type="fig"}, *B*) and D2-40 (anti-Podoplanin, lymphatic immunohistochemical staining). A diagnosis of intramuscular capillary-type hemangioma (or IMH) was made. Because of the persistent growth and the onset of discomfort, it was decided to completely excise under general anesthesia.Fig 2**A**, Hematoxylin-eosin--stained sections of skin tissue show the proliferation of small-diameter, regular capillaries between the skeletal muscle bundles (original magnification, ×100). **B**, Glucose transporter 1 (GLUT 1) immunostaining: negative (original magnification, ×25).

Discussion {#sec3}
==========

IMH was initially described as a type of venous malformation.[@bib2], [@bib3], [@bib4] Currently, it is defined as a benign vascular GLUT1-negative tumor located in skeletal muscle. IMH mainly occurs in young adults and children,[@bib2] but it has been rarely reported in infants. Indeed, the median age of onset was 25 years in a case series including 89 patients[@bib5] and 8.1 years in a case series including exclusively 22 children.[@bib2] To our knowledge, this lesion has never been described in the neonatal period. The origin is unknown, but somatic mutations in *KRAS* and *MAP2K1* have recently been identified in some specimens of IMH.[@bib6] IMHs are characterized by a skin-colored, nonpulsating, nontender soft-tissue mass, mainly located on the limbs and the trunk. The clinical course is stable, or with slow growth, without spontaneous regression, thus differing from infantile hemangioma, which is characterized by rapid growth after birth and slow regression after 12 to 18 months.[@bib7] It also differs from rapidly involuting congenital hemangioma, which has a distinctive evolutive profile, with maximum size at birth and rapid involution over 1 year. In addition, these lesions are more often subcutaneous than intramuscular.[@bib4]^,^[@bib7] Because IMHs have no spontaneous regression, they could be confused with a form of intramuscular noninvoluting congenital hemangioma (NICH), in particular for the nodular clinical subtype.[@bib8] Two clinicals subtypes of NICHs have been described - a patch type and a more protuberant nodular type both are mostly fully formed at birth with a nonprogressive course, and they display typical, coarse telangiectasia and areas of discoloration. In addition, imagery may show calcifications and areas of arterio-venous shunt, never described in IMH.[@bib4]^,^[@bib8] NICHs are very different histologically; they are lobulated vascular tumors composed of small, well-differentiated vessels lined by endothelial cells, with prominent, sometimes hobnailed nuclei. There is a fibrotic stroma containing abnormal large vessels composed of veins, arteries, and lymphatics.[@bib9]

Sonography is required to identify the intramuscular location, and Doppler shows high vascular density with low-resistance arterial flow[@bib4] excluding the diagnosis of intramuscular venous malformation and cystic lymphangioma. The presence of an intra- or periadipocytic contingent is frequently described.[@bib10] Magnetic resonance imagery features include a well-defined mass, with isointense signals in muscle on T1-weighted images.[@bib3]

Only histology including immunostaining can definitively confirm the diagnosis of IMH and eliminate the more serious diagnoses---soft-tissue tumors such as rhabdoid tumor, rhabdomyosarcoma, or infantile fibrosarcoma.

This case of an IMH with features, including the young age at onset and a phase of rapid growth, show that this entity should be included in the differential diagnosis with malignant soft-tissue tumors.
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